Blog
Articles on research peptides, purity verification and laboratory handling. Research use only.
-
2026-07-10
What Is Semax?
Semax is a synthetic heptapeptide derived from ACTH(4-10). An overview of its structure, origin and the research literature, for laboratory reference only.
-
2026-07-12
Semax Research Overview
A structured summary of what the Semax literature reports on BDNF expression, cerebral ischemia models and cognitive tasks — and where the evidence is thin.
-
2026-07-14
Semax vs Other Nootropic-Class Peptides
How Semax's reported mechanism compares with Selank, Noopept and Cerebrolysin in the published peptide research literature.
-
2026-07-16
Semax Forms and Variants
The chemical differences between base Semax and its N-Acetyl amidated variant, and what those changes mean for stability in the research literature.
-
2026-07-18
How to Read a Peptide Certificate of Analysis
What each section of a peptide COA means: HPLC purity trace, mass spectrometry identity confirmation, batch number and issuing laboratory.
-
2026-07-20
What HPLC Purity Actually Measures
How HPLC area-normalisation purity is calculated, what it does not tell you, and why it needs mass spectrometry alongside it.
-
2026-07-22
How to Spot a Low-Quality Research Peptide Vendor
The concrete red flags — missing COAs, unrealistic pricing, no batch data — that indicate a research peptide listing is not what it claims to be.
-
2026-07-24
Peptide Storage Temperature Guide
How storage temperature, light exposure and freeze-thaw cycles affect lyophilised versus reconstituted research peptides.
-
2026-07-27
Buying Research Peptides in Europe
What REACH and CLP mean for ordering research peptides, and what "research use only" means as a legal category in the EU.
-
2026-08-02
BDNF and Neurotrophic Research
What BDNF is, how it signals through TrkB, and why it recurs as an endpoint across the Semax and neuropeptide research literature.
-
2026-08-03
Buying Research Peptides in Germany
What REACH/CLP compliance and language requirements mean for ordering research peptides into Germany, and what documentation to demand.
-
2026-08-05
Buying Research Peptides in the Netherlands
The REACH/CLP framework, dispatch logistics and documentation checklist that apply to ordering research peptides into the Netherlands.
-
2026-08-07
Buying Research Peptides in France
How REACH/CLP and French-language documentation requirements apply to ordering research peptides into France.
-
2026-08-09
Buying Research Peptides in Spain
What REACH/CLP compliance means for a research peptide order shipped into Spain, and the documentation a buyer should demand.
-
2026-08-11
Buying Research Peptides in Italy
How Italy's dual REACH and CLP helpdesk system and language requirements apply to ordering research peptides.
-
2026-08-13
Semax vs Noopept
Semax and Noopept are structurally unrelated research compounds studied through different mechanisms. What each body of literature actually reports, compared directly.
-
2026-08-15
Semax and Intranasal Administration in the Literature
The pharmacological reasoning behind intranasal delivery in Semax studies, and how the nasal route relates to the blood-brain barrier in the published research.
-
2026-08-16
Semax Stability and Degradation
How proteases degrade the Semax sequence, what the PGP tail protects against, and why the N-Acetyl amidated variant exists as a separate research reagent.
-
2026-08-18
ACTH(4-10) Fragment Peptides
The research history of ACTH(4-10) fragment peptides, from early cognition studies in the 1970s to Semax and its structural analogues.
-
2026-08-20
The Research History Behind Semax and Selank
How the Institute of Molecular Genetics programme, associated with Ivan Ashmarin and Nikolai Myasoedov, produced Semax and Selank.